Capital International’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Buy |
44,477
+4,027
| +10% | +$866K | 0.37% | 68 |
|
|
2026
Q1 | $8.8M | Buy |
40,450
+15,158
| +60% | +$3.36M | 0.33% | 84 |
|
|
2025
Q4 | $5.78M | Buy |
25,292
+6,332
| +33% | +$1.44M | 0.2% | 105 |
|
|
2025
Q3 | $4.39M | Sell |
18,960
-149
| -0.8% | -$30.3K | 0.16% | 114 |
|
|
2025
Q2 | $3.55M | Buy |
19,109
+1,406
| +8% | +$261K | 0.14% | 118 |
|
|
2025
Q1 | $3.71M | Sell |
17,703
-19,331
| -52% | -$3.76M | 0.16% | 114 |
|
|
2024
Q4 | $6.58M | Sell |
37,034
-2,202
| -6% | -$405K | 0.27% | 88 |
|
|
2024
Q3 | $7.75M | Buy |
39,236
+817
| +2% | +$152K | 0.33% | 82 |
|
|
2024
Q2 | $6.59M | Sell |
38,419
-152
| -0.4% | -$25.2K | 0.3% | 85 |
|
|
2024
Q1 | $7.02M | Buy |
38,571
+23,718
| +160% | +$4.09M | 0.34% | 84 |
|
|
2023
Q4 | $2.3M | Sell |
14,853
-1,595
| -10% | -$233K | 0.12% | 135 |
|
|
2023
Q3 | $2.45M | Buy |
16,448
+2,810
| +21% | +$413K | 0.14% | 128 |
|
|
2023
Q2 | $1.84M | Hold |
13,638
| – | – | 0.1% | 143 |
|
|
2023
Q1 | $2.17M | Sell |
13,638
-13,448
| -50% | -$2.06M | 0.13% | 137 |
|
|
2022
Q4 | $4.38M | Buy |
27,086
+1,163
| +4% | +$178K | 0.3% | 96 |
|
|
2022
Q3 | $3.48M | Buy |
25,923
+4,878
| +23% | +$700K | 0.24% | 107 |
|
|
2022
Q2 | $3.22M | Buy |
+21,045
| New | +$3.22M | 0.24% | 98 |
|
|
2018
Q3 | – | Sell |
-14,250
| Closed | -$1.32M | – | 128 |
|
|
2018
Q2 | $1.32M | Hold |
14,250
| – | – | 0.23% | 107 |
|
|
2018
Q1 | $1.35M | Hold |
14,250
| – | – | 0.24% | 108 |
|
|
2017
Q4 | $1.38M | Buy |
+14,250
| New | +$1.34M | 0.26% | 99 |
|
|
2016
Q4 | – | Sell |
-14,800
| Closed | -$933K | – | 122 |
|
|
2016
Q3 | $933K | Hold |
14,800
| – | – | 0.07% | 114 |
|
|
2016
Q2 | $916K | Sell |
14,800
-1,800
| -11% | -$110K | 0.07% | 117 |
|
|
2016
Q1 | $948K | Hold |
16,600
| – | – | 0.06% | 139 |
|
|
2015
Q4 | $983K | Sell |
16,600
-18,500
| -53% | -$1.07M | 0.06% | 139 |
|
|
2015
Q3 | $1.91M | Sell |
35,100
-14,400
| -29% | -$937K | 0.13% | 109 |
|
|
2015
Q2 | $3.33M | Sell |
49,500
-13,000
| -21% | -$849K | 0.2% | 97 |
|
|
2015
Q1 | $3.66M | Sell |
62,500
-1,100
| -2% | -$66.5K | 0.22% | 88 |
|
|
2014
Q4 | $4.16M | Sell |
63,600
-264,200
| -81% | -$16.7M | 0.25% | 84 |
|
|
2014
Q3 | $18.9M | Hold |
327,800
| – | – | 1.18% | 31 |
|
|
2014
Q2 | $18.5M | Buy |
327,800
+48,200
| +17% | +$2.53M | 1.14% | 31 |
|
|
2014
Q1 | $14.4M | Buy |
279,600
+203,600
| +268% | +$10.3M | 0.9% | 40 |
|
|
2013
Q4 | $4.01M | Buy |
76,000
+9,500
| +14% | +$467K | 0.25% | 80 |
|
|
2013
Q3 | $2.98M | Buy |
66,500
+26,200
| +65% | +$1.16M | 0.2% | 83 |
|
|
2013
Q2 | $1.67M | Buy |
+40,300
| New | +$1.76M | 0.1% | 99 |
|
Other funds holding ABBV
Capital International's ABBV Position: Q2 2026 in Review
Capital International increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $866K and bringing the position to 44,477 shares worth $11.2M. The position accounts for 0.37% of the portfolio, ranked #68.
Capital International first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. The position peaked at $18.9M in Q3 2014. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Capital International held 44,477 shares of AbbVie worth $11.2M as of Q2 2026.
- Capital International bought 4,027 AbbVie shares in Q2 2026, an estimated $866K.
- AbbVie made up 0.37% of Capital International's portfolio in Q2 2026, its #68 holding.
- Capital International first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- Capital International's AbbVie position peaked at $18.9M in Q3 2014.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.